NCT00078039View on ClinicalTrials.gov

Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

January 31, 2005

Conditions
Schizophrenia
Interventions
DRUG

Paliperidone ER

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00078039 - Trial Evaluating Three Fixed Dosages of Paliperidone Extended-Release (ER) Tablets and Olanzapine in the Treatment of Patients With Schizophrenia | Biotech Hunter | Biotech Hunter